High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

This study has been completed.
Sponsor:
Collaborators:
Wellcome Trust
Global Influenza Program World Health Organization
University of Oxford
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00298233
First received: March 1, 2006
Last updated: March 18, 2010
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)